Cargando…
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation
BACKGROUND: Infants born at extreme prematurity (below 28 weeks' gestation) are at high risk of developmental disability. A major risk factor for disability is having a low level of thyroid hormone which is recognised to be a frequent phenomenon in these infants. At present it is unclear whethe...
Autores principales: | Ng, Sze M, Turner, Mark A, Gamble, Carrol, Didi, Mohammed, Victor, Suresh, Weindling, Alan M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335090/ https://www.ncbi.nlm.nih.gov/pubmed/18366798 http://dx.doi.org/10.1186/1745-6215-9-17 |
Ejemplares similares
-
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: Magnetic Resonance Imaging and Magnetic Resonance Angiography protocol
por: Ng, Sze M, et al.
Publicado: (2008) -
An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks’ gestation: results of the TIPIT trial
por: Ng, Sze M, et al.
Publicado: (2013) -
Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial
por: Ng, Sze May, et al.
Publicado: (2020) -
The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
por: Dargaville, Peter A, et al.
Publicado: (2014) -
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
por: Collins, Carmel T., et al.
Publicado: (2016)